Regiospecific and conformationally restrained analogs of melphalan and dl-2-NAM-7 and their affinities for the large neutral amino acid transporter (system LAT1) of the blood–brain barrier
- 1 June 2010
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12), 3688-3691
- https://doi.org/10.1016/j.bmcl.2010.04.086
Abstract
No abstract availableKeywords
Funding Information
- Department of Defense Breast Cancer Program (W81XWH-062-0033)
- NIH/NINDS (R01 NS052484)
This publication has 16 references indexed in Scilit:
- Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2European Journal of Pharmaceutical Sciences, 2008
- Topoisomerase I inhibitors for the treatment of brain tumorsExpert Review of Anticancer Therapy, 2008
- Increased Permeability of the Blood-Brain Barrier to Chemotherapy in Metastatic Brain Tumors: Establishing a Treatment ParadigmJournal of Clinical Oncology, 2007
- Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality CheckJournal of Clinical Oncology, 2007
- Carrier-mediated transport to enhance drug delivery to brainInternational Congress Series, 2005
- Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrierCancer Chemotherapy and Pharmacology, 1991
- Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain BarrierJournal of Neurochemistry, 1987
- Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-l-sarcolysin and peptichemioEuropean Journal of Cancer and Clinical Oncology, 1987
- Selective cytotoxicity of a system L specific amino acid nitrogen mustardJournal of Medicinal Chemistry, 1987
- Synthesis and analgesic properties of two leucine-enkephalin analogs containing a conformationally restrained N-terminal tyrosine residueJournal of Medicinal Chemistry, 1983